| Metabolic gene polymorphism frequencies in control populations S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ... Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001 | 1140 | 2001 |
| A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages R Van der Geize, K Yam, T Heuser, MH Wilbrink, H Hara, MC Anderton, ... Proceedings of the National Academy of Sciences 104 (6), 1947-1952, 2007 | 715 | 2007 |
| Complement activation and protein adsorption by carbon nanotubes C Salvador-Morales, E Flahaut, E Sim, J Sloan, MLH Green, RB Sim Molecular immunology 43 (3), 193-201, 2006 | 516 | 2006 |
| Nomenclature for N-acetyltransferases KP Vatsis, WW Weber, DA Bell, JM Dupret, DAP Evans, DM Grant, ... Pharmacogenetics and Genomics 5 (1), 1-17, 1995 | 507 | 1995 |
| Metabolic polymorphisms and cancer susceptibility. G Smith, LA Stanley, E Sim, RC Strange, CR Wolf Cancer surveys 25, 27-65, 1995 | 373 | 1995 |
| The covalent-binding reaction of complement component C3 RB Sim, TM Twose, DS Paterson, E Sim Biochemical Journal 193 (1), 115-127, 1981 | 361 | 1981 |
| Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer A Risch, DMA Wallace, S Bathers, E Sim Human molecular genetics 4 (2), 231-236, 1995 | 303 | 1995 |
| Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease ZS Nagy, MM Esiri, KA Jobst, C Johnston, S Litchfield, E Sim, AD Smith Neuroscience 69 (3), 757-761, 1995 | 296 | 1995 |
| Structure of arylamine N-acetyltransferase reveals a catalytic triad JC Sinclair, J Sandy, R Delgoda, E Sim, MEM Noble Nature structural biology 7 (7), 560-564, 2000 | 258 | 2000 |
| Pharmacogenetics of the arylamine N-acetyltransferases NJ Butcher, S Boukouvala, E Sim, RF Minchin The pharmacogenomics journal 2 (1), 30-42, 2002 | 231 | 2002 |
| N-Acetyltransferase polymorphism: comparison of phenotype and genotype in humans D Hickman, E Sim Biochemical pharmacology 42 (5), 1007-1014, 1991 | 228 | 1991 |
| Phenotyping of human complement component C4, a class-III HLA antigen E Sim, SJ Cross Biochemical Journal 239 (3), 763-767, 1986 | 207 | 1986 |
| Expression of arylamine N-acetyltransferase in human intestine D Hickman, J Pope, SD Patil, G Fakis, V Smelt, LA Stanley, M Payton, ... Gut 42 (3), 402-409, 1998 | 184 | 1998 |
| Cloning and Characterization of Arylamine N -Acetyltransferase Genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: Increased Expression … M Payton, R Auty, R Delgoda, M Everett, E Sim Journal of bacteriology 181 (4), 1343-1347, 1999 | 163 | 1999 |
| Arylamine N‐acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery E Sim, A Abuhammad, A Ryan British Journal of Pharmacology 171 (11), 2705-2725, 2014 | 161 | 2014 |
| Current Smoking, Occupation, N-Acetyltransferase-2 and Bladder Cancer: A Pooled Analysis of Genotype-based Studies P Vineis, D Marinelli, H Autrup, J Brockmoller, I Cascorbi, AK Daly, ... Cancer Epidemiology Biomarkers & Prevention 10 (12), 1249-1252, 2001 | 160 | 2001 |
| Arylamine N-acetyltransferases: from structure to function E Sim, K Walters, S Boukouvala Drug metabolism reviews 40 (3), 479-510, 2008 | 159 | 2008 |
| Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with α 2-macroglobulin RB Sim, E Sim Biochemical Journal 193 (1), 129-141, 1981 | 158 | 1981 |
| Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms E Sim, N Lack, CJ Wang, H Long, I Westwood, E Fullam, A Kawamura Toxicology 254 (3), 170-183, 2008 | 157 | 2008 |
| Chromosomal localization of human genes for arylamine N-acetyltransferase D Hickman, A Risch, V Buckle, NK Spurr, SJ Jeremiah, A McCarthy, E Sim Biochemical Journal 297 (3), 441-445, 1994 | 157 | 1994 |
